Understanding Ovarian Cancer Treatment with MT19c
Author Information
Author(s): Stuckey Ashley, Fischer Andrew, Miller Daniel H, Hillenmeyer Sara, Kim Kyu K, Ritz Anna, Singh Rakesh K, Raphael Benjamin J, Brard Laurent, Brodsky Alexander S
Primary Institution: Brown University
Hypothesis
Which genes and pathways are important for the anti-tumor activity of MT19c in ovarian cancer?
Conclusion
MT19c shows significant anti-tumor effects in ovarian cancer by regulating key survival pathways.
Supporting Evidence
- MT19c significantly reduced tumor size in xenograft models.
- PPARĪ³ was up-regulated in treated tumors, suggesting a role in survival.
- MT19c induced DNA degradation consistent with apoptosis.
- Gene expression changes were observed in response to MT19c treatment.
Takeaway
This study looks at how a new treatment for ovarian cancer works and finds that it affects certain genes that help tumors grow.
Methodology
The study used genome-wide mRNA expression and DNA copy number measurements to analyze tumor responses to MT19c.
Potential Biases
Potential bias due to the use of a single xenograft model.
Limitations
The study primarily focuses on a single cell line and may not represent all ovarian cancer types.
Participant Demographics
Nude mice were used for xenograft tumor models.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website